Stocks and Investing Stocks and Investing
Wed, March 3, 2021
Tue, March 2, 2021

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $45 on, Mar 2nd, 2021


Published on 2024-10-27 15:49:39 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $50 to $45 on, Mar 2nd, 2021.

Matthew has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Cory Kasimov of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $39 on, Wednesday, February 17th, 2021
  • Matthew Luchini of "BMO Capital" Downgraded from Buy to Hold and Held Target at $56 on, Thursday, November 5th, 2020


These are the ratings of the 3 analyists that currently disagree with Matthew


  • Yun Zhong of "Berenberg" Initiated at Strong Buy and Held Target at $64 on, Wednesday, November 11th, 2020
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $81 on, Thursday, November 5th, 2020
  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $99 on, Thursday, November 5th, 2020

Contributing Sources